Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia
Taiwan-based Formosa Pharmaceuticals announced today that the company has entered into a collaboration agreement with […]
First Baby Receives Life-Saving Gene Therapy on NHS
A 19-month-old baby girl called Teddi has become the first child in the UK to […]
Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects
Creative Medical Technology, a biotechnology company working to revolutionize care through the development of potentially […]
Avidity Biosciences Receives FDA Orphan Drug Designation for AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy
Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called […]
Univar Solutions Expands Pharmaceutical Ingredients Portfolio Through New Distribution Agreement with SI Group
Univar Solutions Brasil, a subsidiary of Univar Solutions, a leading global solutions provider to users […]
BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers
BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]
Veritas and Jeffrey Modell Foundation Announce a Collaboration to Help Advance Early Diagnosis in Children with Primary Immunodeficiencies
The Jeffrey Modell Foundation (JMF) a global non-profit organization for Primary Immunodeficiency (PI) and Veritas, […]
FSD Pharma Launches A New Research and Development Program Targeting Unmet Medical Needs for Alcohol Misuse
FSD Pharma, a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech […]
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer
Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more